Abstract
Acute Respiratory Distress Syndrome (ARDS) is an inflammatory disease that is associated with high mortality but no specific treatment. Our understanding of initial events that trigger ARDS pathogenesis is limited. We have developed a mouse model of inflammatory lung injury by influenza and methicillin-resistant Staphylococcus aureus (MRSA) coinfection plus daily antibiotic therapy. Using this pneumonic ARDS model, here we show that IFN-γ receptor signaling drives inflammatory cytokine storm and lung tissue damage. By single-cell RNA sequencing (scRNA-seq) analysis, we demonstrate that IFN-γ signaling induces a transcriptional shift in airway immune cells, particularly by upregulating macrophage and monocyte expression of genes associated with inflammatory diseases. Further evidence from conditional knockout mouse models reveals that IFN-γ receptor signaling in myeloid cells, particularly CD11c+ mononuclear phagocytes, directly promotes TNF-α hyperproduction and inflammatory lung damage. Collectively, the findings from this study, ranging from cell-intrinsic gene expression to overall disease outcome, demonstrate that influenza-induced IFN-γ triggers myeloid cell hyperresponsiveness to MRSA, thereby leading to excessive inflammatory response and lethal lung damage during coinfection.
Full Text
Topics from this Paper
Acute Respiratory Distress Syndrome
Signaling In Myeloid Cells
IFN-γ Receptor Signaling
Lethal Lung Injury
Airway Immune Cells
+ Show 5 more
Create a personalized feed of these topics
Get StartedSimilar Papers
Journal of immunology (Baltimore, Md. : 1950)
Sep 1, 2021
The Journal of Immunology
Sep 1, 2021
Frontiers in Pharmacology
Apr 4, 2023
Biochemical Pharmacology
Oct 1, 2018
Chinese Journal of Emergency Medicine
Nov 10, 2013
International immunopharmacology
Jul 1, 2023
Heart, Lung and Circulation
Jun 1, 2021
Seminars in Thoracic and Cardiovascular Surgery
Aug 1, 2022
International Journal of Molecular Sciences
Aug 28, 2020
Molecular Therapy
Dec 1, 2020
Pulmonary Pharmacology & Therapeutics
Oct 1, 2007
Frontiers in Immunology
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023
Frontiers in Immunology
Oct 2, 2023